Today’s drug discovery processes are painful and time-consuming with failure rates of 95%. Experimental methods are not exhaustive and computational tools lack precise prediction power. Our platform scales the generation of real data at the atomic level and grows drug candidates virtually. Established biopharma and AI-driven tech startups still operate in isolation. We integrate both approaches of bio and tech aiming to build a portfolio of drug candidates for selected targets.